Vanta Bioscience Ltd - 540729 - Corporate Insolvency Resolution Process (CIRP)-Intimation of meeting of Committee of Creditors
Intimation of the First Meeting of Committee of Creditors of Vanta Bioscience Limited14-01-2023
14-01-2023
Vanta Bioscience Ltd - 540729 - Corporate Insolvency Resolution Process (CIRP)-Updates - Corporate Insolvency Resolution Process (CIRP)
Final Order Pronouncement by NCLAT11-01-2023
Vanta Bioscience Ltd - 540729 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Voting Results and Scrutinizers Report for AGM held on 31.12.202202-01-2023
Vanta Bioscience Ltd - 540729 - Shareholder Meeting / Postal Ballot-Outcome of AGM
Proceedings of AGM held on 31.12.202231-12-2022
Vanta Bioscience Ltd - 540729 - Corporate Insolvency Resolution Process (CIRP)-Updates - Corporate Insolvency Resolution Process (CIRP)
Updates regarding hearing on November 30, 2022 and December 02, 202214-12-2022
Vanta Bioscience Ltd - 540729 - Corporate Insolvency Resolution Process (CIRP)-Updates - Corporate Insolvency Resolution Process (CIRP)
Updates regarding hearing on November 24, 202227-11-2022
Vanta Bioscience Ltd - 540729 - Corporate Insolvency Resolution Process (CIRP)-Updates - Corporate Insolvency Resolution Process (CIRP)
Updates regarding hearing on November 09, 2022 and November 18, 202224-11-2022
Vanta Bioscience Ltd - 540729 - Results-Delay in Financial Results
Delay in submission of financial results for the half year ended 30.09.202214-11-2022
Vanta Bioscience Ltd - 540729 - Board Meeting Intimation for Approval Of Unaudited Financials (Standalone & Consolidation) For The Half Year Ended 30.09.2022
Vanta Bioscience Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2022 ,inter alia, to consider and approve unaudited financials (standalone & consolidation) for the half year ended 30.09.202208-11-2022